Espoo, Finland (ots/PRNewswire) - - Top quantum expert tapped to lead the new facility http://www.meetiqm.com/ (IQM), today announced an expansion through the establishment of its first subsidiary company, IQM Germany, located in Munich. The company also announced the appointment of renowned quantum computing and ...
Baar, Switzerland and Berlin (ots/PRNewswire) - First 3-year-old patient successfully implanted and discharged from hospital in Berlin CARAG AG, a Swiss privately held medical device development company, announced today the successful implantation of the first-ever transcatheter septal occluder with bioresorbable, ...
European Society for Medical Oncology (ESMO)
London (ots/PRNewswire) - Senzer has secured the Investigational New Drug application and data package for its ongoing FDA registration programme from its former US strategic partner and will now push ahead to get its cannabinoid respiratory device approved for treating side effects induced by anti-cancer treatments ...
Miami (ots/PRNewswire) - ArisGlobal, a leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, is thrilled to announce their participation at the World Drug Safety Congress Americas 2020 ...
Darmstadt, Germany (ots/PRNewswire) - Approval is for ERBITUX® in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN Pivotal Phase III study shows significant improvements with ERBITUX® in combination with platinum-based therapy with fluorouracil in response rate, ...
Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that former Foundation Medicine CEO Troy Cox has been elected as Chairman of the Board of Directors, effective March 1, 2020. He is replacing Antoine Duchateau, who has served as chairman since 2013 and will continue as a board member. Cox joined the ...
Amsterdam (ots/PRNewswire) - - Ferric maltol (FM) was associated with substantially lower use of healthcare resources than IV ferric carboxymaltose (FCM) - IV FCMwas linked to greater productivity loss and disruption to patients' work and family life due to the need for clinic-based IV administration - 50% of ...
Lucerne (ots) - Following its nomination for an eight time in a row as Top Employer Switzerland, MSD (Merck Sharp & Dohme AG) is delighted to announce the introduction of a new gender-neutral parental leave policy to all its employees within ...
Amsterdam (ots/PRNewswire) - - Norgine to receive upfront payments, undisclosed milestone payments along with double-digit percentage royalties - Norgine retains full commercial rights to PLENVU® in all unlicensed countries Norgine B.V. (Norgine), a leading European specialist pharmaceutical company, today ...
Vancouver (ots/PRNewswire) - - Performance BioFilaments Inc. is pleased to announce the availability of high performance nanofibrillated cellulose (NFC) starting in 2021. The construction of a 21 metric tons per day plant, located at Resolute's Kénogami paper mill in Quebec, will ensure a reliable commercial supply of NFC. This wood-derived biomaterial can ...
Ra'anana, Israel (ots/PRNewswire) - SMART's G-EYE® 760R colonoscope, incorporating its G-EYE® Balloon Technology designed to increase the detection of cancerous polyps in colonoscopy, will become available by FUJIFILM Europe with its state-of-the-art ELUXEO system, as part of the newly formed strategic ...
Lucerne (ots) - World Cancer Day every 4th of February is a global uniting movement led by the Union for International Cancer Control (UICC). MSD (Merck Sharp & Dohme) is a proud sponsor of this initiative, joining the conversation to create a groundswell of awareness and action that will enable powerful ...
Lucerne (ots) - - Company will open a new location in Zurich, focused on accelerating research, data and commercialization of our medicines and vaccines - Lucerne will remain the center of MSD's presence in Switzerland MSD (Merck Sharp & Dohme AG) today announced that it will establish a new office in Zurich, Switzerland, aimed at accelerating the ...
Cambridge, England and Milpitas, California (ots/PRNewswire) - Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce the asset purchase of the gene editing platform and oncology product portfolio of Applied StemCell, Inc. (ASC) for life science research and diagnostic ...
Hamamatsu Photonics Europe GmbH
Hamamatsu City, Japan (ots/PRNewswire) - By applying its own unique microelectro-mechanical systems (MEMS) technology, Hamamatsu Photonics has successfully developed a palm-sized "Fourier transform infrared spectrometer (FTIR) engine C15511-01" offering high sensitivity to near-infrared light at wavelengths from 1.1 ...
Prague (ots/PRNewswire) - Zentiva welcomed The Pharmaceutical Applied Research Center (The Parc) to their Prague headquarters to celebrate the first anniversary of The Parc Awards. The Parc is a unique research platform designed to prepare future generations of pharmaceutical scientists and engineers. Twenty-nine students are currently included in the program and an ...
Lucerne (ots) - - Swissmedic approval is based on a significant benefit in overall survival with pembrolizumab in combination with axitinib compared to sunitinib in the Phase III study KEYNOTE-426 - Pembrolizumab is the first PD-1 inhibitor that has ...
London (ots/PRNewswire) - COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant depression with a psilocybin formulation, by the US Patent and Trademark Office. The patent covers the use of COMPASS's ...
London (ots/PRNewswire) - Senzer's pharmaceutical respiratory device will be used in Europe's first and biggest national medical cannabis registry, Project TWENTY21, in which an expected 20,000 patients will be enrolled by the end of 2021 creating the largest body of evidence for the efficacy of medical cannabis. Drug Science, the leading independent scientific body on ...
Tokyo (ots/PRNewswire) - Kyowa Kirin Co., Ltd. (TSE: 4151) President and CEO: Masashi Miyamoto, "Kyowa Kirin") today announces that its marketing authorisation application (MAA) for istradefylline (KW-6002) as an adjunctive treatment to levodopa-based regimens in adult patients with Parkinson's disease (PD) ...
Cambridge, England (ots/PRNewswire) - - Includes leading protein conjugation technologies and industry brands Lightning-Link® and CaptSure(TM) - Opportunity to combine Expedeon and Abcam's technologies to create new products to support research and diagnostic development Abcam plc, a global innovator in life ...
Munich (ots/PRNewswire) - · Results published in the European Heart Journal - Cardiovascular Pharmacotherapy (https://academic.oup.com/ehjcvp/advance-article-abstract/doi/10.1093/ehjcvp/pvz070/5644339?redirectedFrom=fulltext), showed rates of thromboembolism similar to those observed in the ENGAGE AF-TIMI 48 ...
Denver, Colorado (ots/PRNewswire) - Canopy Growth's first line of CBD products are available for purchase through e-commerce platform available at www.firstandfree.com - Canopy Growth Corporation, USA, LLC (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company") today announced the launch of First & Free - a ...
London (ots/PRNewswire) - COMP360 (psilocybin) was well tolerated in healthy volunteers and results support further investigation of simultaneous 1:1 therapeutic administration design COMPASS Pathways, a mental health care company, has reported that its COMP360 (psilocybin) was well-tolerated when administered to ...
Stuttgart, Germany (ots/PRNewswire) - Revenue increases by 11 percent to 6.4 billion euros - EBIT exceeds 1 billion euros for the first time - All four segments contributed to growth - Medical technology and industrial and research solutions ensure above-average growth for the ZEISS Group - Semiconductor Manufacturing Technology sees strong growth with new EUV technology - ZEISS CEO Michael Kaschke: "As a global ...
Aachen, Germany (ots/PRNewswire) - Grünenthal announced today that Jan Adams, MD has been appointed Chief Scientific Officer (CSO) and Member of the Corporate Executive Board effective 1 January 2020. Since July 2019, Jan has already served as acting CSO, leading the strategic re-alignment of Grünenthal's R&D organisation. Jan brings over 15 years of experience in healthcare and the biopharmaceutical industry. He joined ...
Brussels (ots/PRNewswire) - - Phase II data demonstrate that rozanolixizumab was well tolerated by patients with primary ITP across all dose groups - Clinically relevant improvements in platelet count and decrease in immunoglobin G (IgG) levels were observed in all dose groups - Safety, tolerability and efficacy ...
APR Applied Pharma Research s.a.
Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa ("APR"), the Swiss pharma company focused in niche and rare therapeutic areas, announces that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for its investigational drug code-named APR-TD011 for treatment of ...